FDA Orange Book · active-ingredient family
Mometasone furoate; olopatadine hydrochloride
Mometasone furoate; olopatadine hydrochloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:RYALTRIS · NDA 211746
1
Brand (NDA)
0
Generics (ANDA)
16
Listed patents
0
Exclusivity periods
Brand (NDA) products · spray, metered
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| RYALTRISRLD | GLENMARK SPECLT | NDA 211746 | — | Jan 13, 2022 |
Listed patents (16)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10765686 | Sep 04, 2034 | in 8 yr 4 mo | U-3295 |
| 10758550 | Sep 04, 2034 | in 8 yr 4 mo | U-3296 |
| 10646500 | Sep 04, 2034 | in 8 yr 4 mo | U-3297 |
| 10548907 | Sep 04, 2034 | in 8 yr 4 mo | U-3297 |
| 11400101 | Sep 04, 2034 | in 8 yr 4 mo | U-3297 |
| 12064442 | Sep 04, 2034 | in 8 yr 4 mo | U-3297 |
| 10016443 | Sep 04, 2034 | in 8 yr 4 mo | U-3297 |
| 10517880 | Sep 04, 2034 | in 8 yr 4 mo | ProductU-3297 |
| 9750754 | Sep 04, 2034 | in 8 yr 4 mo | ProductU-3297 |
| 9078923 | Sep 04, 2034 | in 8 yr 4 mo | ProductU-3297 |
| 10561672 | Sep 04, 2034 | in 8 yr 4 mo | Product |
| 9370483 | Sep 04, 2034 | in 8 yr 4 mo | Product |
| 10376526 | Sep 04, 2034 | in 8 yr 4 mo | Product |
| 9937189 | Sep 04, 2034 | in 8 yr 4 mo | Product |
| 11679210 | Sep 03, 2038 | in 12 yr 5 mo | Product |
| 12303635 | Apr 08, 2039 | in 13 yr | SubstanceProduct |
Mometasone furoate; olopatadine hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
